Qian, Z. R., Ter-Minassian, M., Chan, J. A., Imamura, Y., Hooshmand, S. M., Kuchiba, A., . . . Kulke, M. H. (2013). Prognostic Significance of MTOR Pathway Component Expression in Neuroendocrine Tumors. American Society of Clinical Oncology.
Citação norma ChicagoQian, Zhi Rong, et al. Prognostic Significance of MTOR Pathway Component Expression in Neuroendocrine Tumors. American Society of Clinical Oncology, 2013.
MLA引文Qian, Zhi Rong, et al. Prognostic Significance of MTOR Pathway Component Expression in Neuroendocrine Tumors. American Society of Clinical Oncology, 2013.
警告：這些引文格式不一定是100％准確.